Risk of second malignant neoplasms after childhood leukemia and lymphoma: An international study

Journal of the National Cancer Institute

Volumn 99, Issue 10, 2007, Pages 790-800

  Maule, Milena ^a   Scélo, Ghislaine ^c   Pastore, Guido ^a,b   Brennan, Paul ^c   Hemminki, Kari ^d,e   Tracey, Elizabeth ^f   Sankila, Risto ^g   Weiderpass, Elisabete ^e,h   Olsen, Jorgen H ⁱ   McBride, Mary L ^j   Brewster, David H ^k   Pompe Kirn, Vera ^l   Kliewer, Erich V ^m,n   Chia, Kee Seng ^o,p   Tonita, Jon M ^q   Martos, Carmen ^r   Jonasson, Jon G ^s,t   Merletti, Franco ^a   Boffetta, Paolo ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e KAROLINSKA INSTITUTE   (Sweden)

^f New South Wales Cancer Registry   (Australia)

^g FINNISH CANCER REGISTRY   (Finland)

^h CANCER REGISTRY OF NORWAY   (Norway)

ⁱ INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^j BRITISH COLUMBIA CANCER AGENCY   (Canada)

^k INFORMATION SERVICES DIVISION   (United Kingdom)

^l INSTITUTE OF ONCOLOGY   (Slovenia)

^m Epidemiology and Cancer Registry   (Canada)

ⁿ UNIVERSITY OF MANITOBA   (Canada)

^o Center for Molecular Epidemiology   (Singapore)

^p Singapore Cancer Registry   (Singapore)

^q SASKATCHEWAN CANCER AGENCY   (Canada)

^r Cancer Registry of Zaragoza   (Spain)

^s ICELANDIC CANCER REGISTRY   (Iceland)

^t UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVOR; CHILD; CHILDHOOD LEUKEMIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROUPS BY AGE; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; SECOND CANCER; SKIN TUMOR; STANDARDIZATION; STATISTICAL ANALYSIS; THYROID CANCER; CLINICAL TRIAL; LEUKEMIA; LYMPHOMA; MULTICENTER STUDY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; REGISTER; RISK FACTOR; STATISTICS; SURVIVOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA; LYMPHOMA; MALE; NEOPLASMS, SECOND PRIMARY; REGISTRIES; RISK FACTORS; SURVIVORS;

EID: 34447285007     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk180     Document Type: Article

References (60)

1. Terracini B, Coebergh JW, Gatta G, Magnani C, Stiller C, Verdecchia A, et al. Childhood cancer survival in Europe: An overview. Eur J Cancer 2001;37:810-6.
2. Coebergh JW, Pastore G, Gatta G, Corazziari I, Kamps W. Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978-1992: The EUROCARE study. Eur J Cancer 2001;37: 687-94.
3. Pastore G, Magnani C, Verdecchia A, Pession A, Viscomi S, Coebergh JW. Survival of childhood lymphomas in Europe, 1978-1992: A report from the EUROCARE study. Eur J Cancer 2001;37:703-10.
4. Gatta G, Corazziari I, Magnani C, Peris-Bonet R, Roazzi P, Stiller C. Childhood cancer survival in Europe. Ann Oncol 2003;14(Suppl 5): V119-27.
5. Kaatsch P, Spix C. German Childhood Cancer Registry. Annual Report 2004. Ivailable at: http:/info.imsd.uni-mainz.de/K_Krebsregister/english/. [Last accessed: April 2006.]
6. Steliarova-Foucher E, Stiller C, Kaatsch P. Berrino F, Coebergh JW, Lacour B, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): An epidemiological study. Lancet 2004;364: 2097-105.
7. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al., editors. SEER Cancer Statistics Review, 1975-2003. Bethesda (MD): National Cancer Institute; 2005.
8. Douglas NM, Dockerty JD. Population-based survival of children in New Zealand diagnosed with cancer during 1990-1993. Ent J Cancer 2005;41:1604-9.
9. Ajiki W, Tsukuma H, Oshima A. Survival rates of childhood cancer patients in Osaka, Japan. Jpn J Clin Oncol 2004;34:50-4.
10. Hewitt MWS, Simone JV, editors. Childhood cancer survivorship: Improving care and quality of life. Washington (DC): National Academies Press; 2003.
11. Cancer incidence in five continents. Volume VIII. IARC Sci Publ 2002;155:1-781.
12. Olsen JH, Garwicz S, Hertz H, Jonmundsson G, Langmark F, Lanning M, et al. Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ 1993;307:1030-6.
13. Jazbec J, Ecimovic P, Jereb B. Second neoplasms after treatment of childhood cancer in Slovenia. Pediatr Blood Cancer 2004;42:574-81.
14. Slee VN. The International Classification of Diseases: Ninth revision (ICD-9). Ann Intern Med 1978;88:424-6.
15. Muir CS, Percy C. Classification and coding for neoplasms. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. IARC Scientific Publication No. 95. Cancer registration - principles and methods. Vol I. Lyon (France): IARC; 1991.
16. Breslow NE, Day NE. Statistical methods in cancer research. Volume II - the design and analysis of cohort studies. IARC Sci Publ 1987;82:65-72.
17. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999;18:695-706.
18. Woodward M. Epidemiology - Study design and data analysis. 2nd ed. Boca Raton (FL): Chapman & Hall; 1999.
19. World Health Organization ROfE. European mortality database (MDB): World Health Organization; 2007. Available at: http://www.euro.who.int/ InformationSources/Data/20010827_1. [Last accessed; April 2007.]
20. Breslow NE, Day NE. Statistical methods in cancer research. Volume II - the design and analysis of cohort studies. IARC Sci Publ 1987;82: 96-8.
21. Bhatia S, Meadows AT. Long-term follow-up of childhood cancer survivors: future directions for clinical care and research. Pediatr Blood Cancer 2006;46:143-8.
22. Hammal DM, Bell CL, Craft AW, Parker L. Second primary tumors in children and young adults in the North of England (1969-99). Pediatr Blood Cancer 2005;45:155-61.
23. Jenkinson HC, Hawkins MM, Stiller CA, Winter DL, Marsden HB, Stevens MC. Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer 2004;91:1905-10.
24. Klein G, Michaelis J, Spix C, Wibbing R, Eggers G, Ritter J, et al. Second malignant neoplasms after treatment of childhood cancer. Eur J Cancer 2003;39:808-17.
25. Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 2003;349:640-9.
26. Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002;99:4257-64.
27. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study. J Natl Cancer Inst 2001;93:618-29.
28. Haupt R, Valsecchi MG, Silvestri D, De Lorenzo P, Napoli S, Masera G, et al. Early and late deaths after elective end of therapies for childhood cancer in Italy. Int J Cancer 2000;86:393-8.
29. Westermeier T, Kaatsch P, Schoetzau A, Michaelis J. Multiple primary neoplasms in childhood: Data from the German Children's Cancer Registry. Eur J Cancer 1998;34:687-93.
30. Hawkins MM, Wilson LM, Burton HS, Potok MH, Winter DL, Marsden HB, et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996;88:270-8.
31. Magnani C, Terracini B, Cordero Di Montezemolo L, Gallone G, Luzzatto L, Mosso ML, et al. Incidence of second primary malignancies after a malignant tumor in childhood: A population-based survey in Piedmont (Italy). Int J Cancer 1996;67:6-10.
32. Sankila R, Garwicz S, Olsen JH, Dollner H, Hertz H, Kreuger A, et al. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology. J Clin Oncol 1996;14:1442-6.
33. de Vathaire F, Schweisguth O, Rodary C, Francois P, Sarrazin D, Oberlin O, et al. Long-term risk of second malignant neoplasm after a cancer in childhood. Br J Cancer 1989;59:448-52.
34. Hawkins MM. Long-term survivors of childhood cancers: What knowledge have we gained? Nat Clin Pract Oncol 2004;1:26-31.
35. Inskip PD. Second cancers following radiotherapy. In: Neugut AI, Meadows AT, Robinson E, editors. Multiple primary cancers. Philadelphia (PA): Lippincott William & Wilkins; 1999. p. 91-136.
36. Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia (PA): Lippincott William & Wilkins; 2006.
37. Magnani C, Pastore G, Coebergh JW, Viscomi S, Spix C, Steliarova-Foucher E. Trends in survival after childhood cancer in Europe, 1978-1997: report from the Automated Childhood Cancer Information System project (ACCIS). Eur J Cancer 2006;42:1981-2005.
38. Gatta G, Capocaccia R, Coleman MP, Ries LA, Berrino F. Childhood cancer survival in Europe and the United States. Cancer 2002;95: 1767-72.
39. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166-78.
40. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004;350:1535-48.
41. Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FB, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991;325:1330-6.
42. Meadows AT, Gordon J, Massari DJ, Littman P, Fergusson J, Moss K. Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet 1981;2:1015-8.
43. Jankovic M, Brouwers P, Valsecchi MG, Van Veldhuizen A, Huisman J, Kamphuis R, et al. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet 1994;344:224-7.
44. Nygaard R, Garwicz S, Haldorsen T, Hertz H, Jonmundsson GK, Lanning M, et al. Second malignant neoplasm in patients treated for childhood leukemia. A population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO). Acta Paediatr Scand 1991;80:1220-8.
45. Tucker MA, Jones PH, Boice JD Jr, Robison LL, Stone BJ, Stovall M, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res 1991;51:2885-8.
46. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study. Lancet 2005;365:2014-23.
47. Kenney LB, Yasui Y, Inskip PD, Hammond S, Neglia JP, Mertens AC, et al. Breast cancer after childhood cancer: A report from the Childhood Cancer Survivor Study. Ann Intern Med 2004;141:590-7.
48. Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol 2005;23:3733-41.
49. Ng AK, Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors. Blood 2002;100:1989-96.
50. Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 2005;97: 1428-37.
51. Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003;290:465-75.
52. Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 2006.
53. Yahalom J. Breast cancer after Hodgkin disease: Hope for a safer cure. JAMA 2003;290:529-31.
54. Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, et al. Risk of selected subsequent carcinoma in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2006;24:476-83.
55. Schonfeld SJ, Gilbert ES, Dores GM, Lynch CF, Hodgson DC, Hall P, et al. Acute myeloid leukemia following Hodgkin lymphoma: A population-based study of 35,511 patients. J Natl Cancer Inst 2006;98: 215-8.
56. Pedersen-Bjergaard J, Ersboll J, Hansen VL, Sorensen BL, Christoffersen K, Hou-Jensen K, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med 1988;318:1028-32.
57. Travis LB, Curtis RE, Glimelius B, Holowaty EJ, Van Leeuwen FE, Lynch CF, et al. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 1995;87: 524-30.
58. Kersun LS, Wimmer RS, Hoot AC, Meadows AT. Secondary malignant neoplasm of the bladder after cyclophosphamide treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 2004;42: 289-91.
59. Pui CH. Childhood leukemias. N Engl J Med 1995;332:1618-30.
60. Alberts DS. Second cancers are killing us! Cancer Epidemiol Biomarkers Prev 2006;15:2019.